6 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Medications #Pharmacology ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Summary of Non-Insulin ... #Diabetes #Pharmacology ... #Comparison #Table ... Medications #Noninsulin #Orals ... #Agents
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... Improved outcomes in CKD
NSAID Dosing in CKD
 • Carboxylic Acids: Salsalate, Choline Mg trisalicylate
 • Acetic Acids: Indomethacin, Tolmetin,
NSAID Dosing in ... trisalicylate • Acetic ... Nabumetone • COX-2 Inhibitors ... #CKD #pharmacology ... #table
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
suspension DOSING ... patients with CKD ... , HF, or diabetes ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
anticoagulation in North America ... direct acting oral ... clearance (calculated using ... per treatment table ... Management #Treatment #pharmacology